Celiac Disease
An autoimmune disorder where consuming gluten damages the small intestine, affecting 1% of people and often going undiagnosed for years.
Overview
Celiac disease is a lifelong autoimmune condition triggered by gluten ingestion in genetically susceptible individuals. An estimated 1 in 133 Americans (approximately 1% of the population) has celiac disease, yet up to 83% remain undiagnosed or have been misdiagnosed with other conditions. When someone with celiac disease consumes gluten (a protein found in wheat, barley, and rye), the immune system attacks the lining of the small intestine, damaging the villi, the tiny finger-like projections responsible for nutrient absorption.
The condition produces a wide range of symptoms that can involve multiple organ systems. While gastrointestinal symptoms are the most recognized, many individuals experience extraintestinal manifestations affecting the skin, bones, nervous system, and other organs. Only 10% to 20% of affected individuals present with the classic, fully developed form. The majority have atypical symptoms, few symptoms, or none at all, which contributes to significant diagnostic delays, often spanning several years.
Symptoms
Common Causes
Celiac disease develops exclusively in individuals who carry specific genetic markers and consume gluten. More than 97% of people with celiac disease in the United States carry the HLA-DQ2 and/or HLA-DQ8 gene variants, compared to approximately 40% of the general population. However, possessing these genes is necessary but not sufficient for developing the disease; additional triggers are required.
Research suggests that among genetically predisposed children, higher gluten consumption in early childhood may increase celiac disease risk. A higher number of early-life infections and certain gastrointestinal infections may also play a role in triggering the disease. Physical stressors such as viral illness, surgery, pregnancy, or significant emotional trauma may serve as activating events. Family history substantially elevates risk: first-degree relatives (parents, siblings, and children) of someone with celiac disease have roughly a 1 in 10 chance of developing the condition, compared to about 1 in 100 in the general population.
When to Get Tested
Testing should be considered for anyone with persistent digestive symptoms like chronic diarrhea, abdominal pain, bloating, or unexplained weight loss, particularly when these symptoms have not responded to standard treatments. Testing may also be appropriate for individuals with unexplained iron-deficiency anemia, recurring headaches, chronic fatigue, or other symptoms that interfere with daily functioning.
Family members of people diagnosed with celiac disease should consider screening, given their substantially elevated risk (approximately 1 in 10 for first-degree relatives). Individuals with other autoimmune disorders, particularly type 1 diabetes or autoimmune thyroid disease, may also benefit from celiac screening, even in the absence of obvious gastrointestinal symptoms.
Recommended Tests
This comprehensive panel screens for celiac-specific antibodies including tissue transglutaminase (tTG) and measures total IgA levels to ensure accurate results. It's the primary test for diagnosing celiac disease and monitoring treatment response.
Iron deficiency anemia is one of the most common signs of celiac disease due to intestinal damage that impairs iron absorption. This panel helps identify iron deficiency that may indicate celiac-related malabsorption.
Vitamin D deficiency is common in celiac disease due to intestinal damage affecting fat-soluble vitamin absorption. Low levels can contribute to bone problems and may indicate the need for celiac screening.
A CBC can detect anemia and other blood abnormalities commonly seen in celiac disease. It helps assess the overall impact of nutrient malabsorption on blood cell production.
This panel evaluates overall health and can detect electrolyte imbalances, liver function changes, and other metabolic issues that may result from celiac disease-related malabsorption.
Determines genetic predisposition for celiac disease; negative result essentially rules out the condition.
Measures intestinal inflammation to distinguish inflammatory bowel disease from irritable bowel syndrome.
Understanding Results
Positive celiac antibody tests suggest the condition but must be interpreted alongside symptoms and other clinical information. The tTG-IgA test detects celiac disease in approximately 93% of affected individuals who are consuming a gluten-containing diet. Elevated antibodies can occasionally appear in other autoimmune conditions, so confirmatory evaluation by a healthcare provider is important for a definitive diagnosis.
Supplementary tests like iron panels and vitamin levels provide valuable supporting data. Low iron, vitamin D, or vitamin B12 may indicate malabsorption consistent with celiac-related intestinal damage, as nutritional deficiencies are common at the time of diagnosis. A critical requirement for accurate testing is that the individual must be eating a gluten-containing diet at the time of antibody testing; removing gluten before testing can produce falsely negative results and delay diagnosis.
Lifestyle & Prevention
A strict, lifelong gluten-free diet is currently the only effective treatment for celiac disease. This means eliminating all foods and beverages containing wheat, barley, rye, and their derivatives. Careful label reading is essential, as gluten can appear in unexpected products including medications, supplements, sauces, and even cosmetics that might be inadvertently ingested.
Maintaining a strict gluten-free diet allows the intestinal lining to heal and symptoms to resolve, though recovery may take months to years depending on the extent of prior damage. Working with a dietitian experienced in celiac disease can help ensure nutritional needs are fully met while avoiding all gluten sources. Regular follow-up testing monitors antibody levels and nutritional status to confirm that the diet is effectively managing the condition.
Privacy & confidentiality
Your celiac disease testing is completely confidential and private. Results are not added to your medical records unless you choose to share them with your healthcare provider. Your employer and insurance company will not be notified of your test results. No doctor visit is required to order testing, allowing you to take control of your health privately and discreetly.
Frequently asked questions
Last reviewed: April 2026
This page is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider regarding any health concerns. LevelPanel does not diagnose, treat, or prescribe.